Completed
This workshop, held in collaboration with the Forum on Cyber Resilience, examined opportunities and challenges for the use of digital health applications in oncology. Workshop presentations and discussions included topics such as validation, data security, and patient privacy issues.
Featured publication
Workshop
ยท2021
Digital health encompasses a broad array of tools and strategies with the goals of advancing research, increasing health care access and quality, and making care more personalized. It encompasses health content, digital health interventions, and digital applications, such as communication tools conn...
View details
Description
A planning committee of the National Academies of Sciences, Engineering, and Medicine will plan and host a 1.5-day public workshop that will examine opportunities and challenges, including validation, data security, and patient privacy issues, for the use of digital health applications in oncology. The workshop will feature invited presentations and panel discussions on topics such as:
- An overview of existing and emerging digital health applications and the potential benefits and risks associated with their use
- Strategies to validate digital health applications, regulate their use, and mitigate potential risks associated with their use
- Strategies for protecting the security of data collected using digital health applications
- Patient privacy considerations, especially given the potential for data linkage with data from other sources of personal information
- Best practices and principles for access to and consent for the use of patient data generated by digital health applications
- Ways to integrate patient-generated health data into EHRs and clinical workflow
- Lessons learned from other industries and/or countries that could inform digital health application development and use.
The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Sponsors
American Association for Cancer Research
American College of Radiology
American Society of Clinical Oncology
Association of American Cancer Institutes
Association of Community Cancer Centers
Bristol Myers Squibb
Cancer Support Community
Centers for Disease Control and Prevention (CDC)
CEO Roundtable on Cancer
Flatiron Health
Merck
National Cancer Institute
National Comprehensive Cancer Network
National Institutes of Health
National Patient Advocate Foundation
Novartis Oncology
Oncology Nursing Society
Pfizer Inc.
Society for Immunotherapy of Cancer
Staff
Erin Balogh
Lead
Sharyl Nass
Lead
Lori Brenig
Annalee Espinosa Gonzales
Emily Zevon
Katherine Hawthorne